(Q48888451)

16 February 2018

title

Benefits and risks of anemia correction with recombinant human erythropoietin in children maintained by hemodialysis. (English)

1 reference

16 February 2018

1 reference

1

1 reference

16 February 2018

Eugenio Baraldi

1 reference

ORCID Public Data File 2021

author name string

Zacchello G

2

1 reference

16 February 2018

Baraldi E

3

1 reference

16 February 2018

Zanconato S

4

1 reference

16 February 2018

Suppiej A

5

1 reference

16 February 2018

Fabris F

6

1 reference

16 February 2018

Andreetta B

7

1 reference

16 February 2018

Pavanello L

8

1 reference

16 February 2018

Zacchello F

9

1 reference

16 February 2018

language of work or name

English

0 references

publication date

1 October 1990

1 reference

16 February 2018

The Journal of Pediatrics

published in

1 reference

16 February 2018

volume

117

1 reference

16 February 2018

issue

4

1 reference

16 February 2018

page(s)

556-560

1 reference

16 February 2018

The anemia of chronic renal failure: pathophysiology and the effects of recombinant erythropoietin

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

Bleeding in renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

Recombinant human erythropoietin: implications for nephrology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

Pathogenesis of cerebral atrophy in uraemia. State of the art

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

Cardiovascular impairment and physical working capacity in children with chronic renal failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

Use of subcutaneous recombinant human erythropoietin in children undergoing continuous cycling peritoneal dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

Brainstem auditory evoked potentials (BAEPs) in childhood migraine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

A comparison of gas exchange indices used to detect the anaerobic threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

The possible value of platelet aggregation studies in patients with increased platelet number

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

Bleeding time in Uremia: A useful test to assess clinical bleeding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2805%2980688-2

10.1016/S0022-3476(05)80688-2

7 January 2021

Identifiers

DOI

1 reference

16 February 2018

1 reference

16 February 2018